Literature DB >> 16344439

Technetium tc 99m-labeled red blood cells in the preoperative diagnosis of cavernous hemangioma and other vascular orbital tumors.

Ennio Polito1, Luca Burroni, Patrizia Pichierri, Antonio Loffredo, Angelo G Vattimo.   

Abstract

OBJECTIVES: To evaluate technetium Tc 99m (99mTc) red blood cell scintigraphy as a diagnostic tool for orbital cavernous hemangioma and to differentiate between orbital masses on the basis of their vascularization.
METHODS: We performed 99mTc red blood cell scintigraphy on 23 patients (8 female and 15 male; mean age, 47 years) affected by an orbital mass previously revealed with computed tomography (CT) and magnetic resonance imaging (MRI) and suggesting cavernous hemangioma. In our diagnosis, we considered the orbital increase delayed uptake with the typical scintigraphic pattern known as perfusion blood pool mismatch. The patients underwent biopsy or surgical treatment with transconjunctival cryosurgical extraction when possible.
RESULTS: Single-photon emission tomography (SPET) showed intense focal uptake in the orbit corresponding to radiologic findings in 11 patients who underwent surgical treatment and pathologic evaluation (9 cavernous hemangiomas, 1 hemangiopericytoma, and 1 lymphangioma). Clinical or histologic examination of the remaining 22 patients revealed the presence of 5 lymphoid pseudotumors, 2 lymphomas, 2 pleomorphic adenomas of the lacrimal gland, 1 astrocytoma, 1 ophthalmic vein thrombosis, and 1 orbital varix.
CONCLUSIONS: The confirmation of the preoperative diagnosis by 99mTc red blood cell scintigraphy shows that this technique is a reliable tool for differentiating cavernous hemangiomas from other orbital masses (sensitivity, 100%; specificity, 86%) when ultrasound, CT, and MRI are not diagnostic. Unfortunately, 99mTc red blood cell scintigraphy results were positive in 1 patient with hemangiopericytoma and 1 patient with lymphangioma, which showed increased uptake in the lesion on SPET images because of the vascular nature of these tumors. Therefore, in these cases, the SPET images have to be integrated with data regarding clinical preoperative evaluation and CT scans or MRI studies. On the basis of our study, a complete diagnostic picture, CT scans or MRI studies, and scintigraphic patterns can establish the preoperative diagnosis of vascular orbital tumors such as cavernous hemangioma, adult-type lymphangioma, and hemangiopericytoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344439     DOI: 10.1001/archopht.123.12.1678

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  The underestimated incidence of an orbital angioleiomyoma is possibly associated with an orbital cavernous hemangioma: illustrative case.

Authors:  Seonah Choi; JaeSang Ko; Se Hoon Kim; Eui Hyun Kim
Journal:  J Neurosurg Case Lessons       Date:  2021-05-24

2.  Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging.

Authors:  Bela S Purohit; Maria Isabel Vargas; Angeliki Ailianou; Laura Merlini; Pierre-Alexandre Poletti; Alexandra Platon; Bénédicte M Delattre; Olivier Rager; Karim Burkhardt; Minerva Becker
Journal:  Insights Imaging       Date:  2015-10-31

3.  The application of technetium-99m-red blood cell scintigraphy in the diagnosis of orbital cavernous hemangioma.

Authors:  Hua Dong; Zuncheng Zhang; Yongtao Guo; Hong Zhang; Wengui Xu
Journal:  Nucl Med Commun       Date:  2017-09       Impact factor: 1.690

4.  Sub-Diaphragmatic Haemangioma Suspected on F-18 Fdg Pet/Ct Confirmed by Rbc Scintigraphy.

Authors:  Arun Prashanth; Deepanksha Datta; Rajesh Kumar; Sameer Taywade; Ravi Chandran; Rakesh Pandey
Journal:  Indian J Nucl Med       Date:  2022-07-08

5.  A case of intraorbital hemangioma diagnosed with tc 99m labeled erythrocyte scintigraphy and magnetic resonance imaging.

Authors:  Tansel Ansal Balcı; Zeyra Pınar Koc; Burak Turgut; Ayse Murat Aydın; Bedriye Busra Demirel
Journal:  Mol Imaging Radionucl Ther       Date:  2011-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.